Professor Emeritis
Pathology
Dr. Raymond B. Nagle, MD
|
|
Give Review
Dr. Raymond B. Nagle practices Pathology. He attended University of Washington School of Medicine. Raymond Nagle is also published. He has 51 publications published. The lastest publication: "Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.' Doctor Raymond B. Nagle, MD is registered with Medicare.
Publications
- Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
- Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis.
- Targeting Integrin A6 stimulates curative-type bone metastasis lesions in a xenograft model.
- ERG Overexpression and PTEN Status Predict Capsular Penetration in Prostate Carcinoma.
- Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer.
- Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
- Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities.
- ERK Crosstalks with 4EBP1 to Activate Cyclin D1 Translation During Quinol-Thioether Induced Tuberous Sclerosis Renal Cell Carcinoma.
- Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer.
- Differences in characteristics of men with localized prostate cancer who demonstrate low, intermediate or high PSA velocity.
- Metastasis Update: Human Prostate Carcinoma Invasion via Tubulogenesis.
- Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
- Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in res...
- The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.
- Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.
- Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317.
- Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer.
- Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer.
- Sympathetic nerves in the tarsal tunnel: implications for blood flow in the diabetic foot.
- Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
- Cross-validation of murine UV signal transduction pathways in human skin.
- Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.
- Integrin A6 Cleavage in Mouse Skin Tumors.
- The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
- Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
- Integrin alpha6 cleavage: a novel modification to modulate cell migration.
- A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ ...
- Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.
- Human laminin-5 and laminin-10 mediated gene expression of prostate carcinoma cells.
- Expression of mTOR signaling pathway markers in prostate cancer progression.
- 90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression.
- Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
- Stimulated endothelial cell adhesion and angiogenesis with laminin-5 modification of expanded polytetrafluoroethylene.
- Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.
- Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue.
- Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.
- Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
- Immunohistochemical comparison of vascular and sinusoidal adherens junctions in cavernosal endothelium.
- Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
- Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.
- Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubertal [correction of prepubetal] benign prostate glands and adult benign and malignant prostate g...
- Androgens block interleukin-1 beta-induced promatrilysin expression in prostate carcinoma cells.
- Consensual interpretive guidelines for diagnostic immunohistochemistry.
- Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.
- Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites.
- Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants.
- Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
- Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.
- Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population.
- Serum protein acidic and rich in cysteine (SPARC) as a prognostic marker in soft tissue sarcomas.
Schools
Univ Of Wa Sch Of Med
University of Washington
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Washington -
University of Washington School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609965730 |
| Last Name Of The Provider | NAGLE |
| First Name Of The Provider | RAYMOND |
| View All |
Similar Doctors
|
|
Dr. David W. Henley, MD |
|
|
Dr. Olivia T. Garza, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Gardetto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ludwig M. Deppisch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen W. Renner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret A. Rennels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane R. Fernandez, MD |
|
|
Dr. Christopher P. Geffre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad E. Wheeler, MD
This Doctor is OpenDoctor Recommended.
|